Nektar Therapeutics (NKTR)

Nektar Therapeutics (NKTR $59.92)
- $59.92 Cap: $1.13B
- View NKTR Profile
- View Questions on NKTR

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Biogen Inc. (BIIB $151.44)
- $151.44 P/E (TTM): 14.08X Cap: $22.63B
- View BIIB Profile
- View Questions on BIIB
FLIR Systems Inc. (FLIR $57.34)
- $57.34 P/E (TTM): 33.53X Cap: $7.56B
- View FLIR Profile
- View Questions on FLIR
Cognex Corporation (CGNX $41.70)
- $41.70 P/E (TTM): 63.68X Cap: $6.93B
- View CGNX Profile
- View Questions on CGNX
Arista Networks Inc. (ANET $157.59)
- $157.59 P/E (TTM): 61.84X Cap: $198.19B
- View ANET Profile
- View Questions on ANET
Nektar Therapeutics (NKTR $59.92)
- $59.92 Cap: $1.13B
- View NKTR Profile
- View Questions on NKTR
Rapid7 Inc. (RPD $18.68)
- $18.68 P/E (TTM): 44.07X Cap: $1.20B
- View RPD Profile
- View Questions on RPD

Q: I hold the above and they all had favorable comments from 5i on growth at one point. Is growth still intact? Do you see anything that's changed in the companies or the environment that would affect any of these? They are inside an RSP for long term growth. TIA!

Read Answer Asked by Wayne on August 17, 2018

Nektar Therapeutics (NKTR $59.92)
- $59.92 Cap: $1.13B
- View NKTR Profile
- View Questions on NKTR

Q: Hi Peter and Ryan,

What is your outlook on Nektar Therapeutic?

Would you be a buyer after it's experiment of cancer drug disappointment.

Thank you for your help as always.

Read Answer Asked by Pui on June 14, 2018

Garmin Ltd. (Switzerland) (GRMN $210.54)
- $210.54 P/E (TTM): 26.38X Cap: $41.14B
- View GRMN Profile
- View Questions on GRMN
Ebix Inc. (EBIX)
- P/E (TTM): 7.25X Cap: $35M
- View EBIX Profile
- View Questions on EBIX
Exact Sciences Corporation (EXAS $66.98)
- $66.98 Cap: $12.68B
- View EXAS Profile
- View Questions on EXAS
Collectors Universe Inc. (CLCT $91.92)
- $91.92 P/E (TTM): 47.28X Cap: $852M
- View CLCT Profile
- View Questions on CLCT
Issuer Direct Corporation (ISDR)
- Cap: $36M
- View ISDR Profile
- View Questions on ISDR
Ichor Holdings (ICHR $22.92)
- $22.92 Cap: $778M
- View ICHR Profile
- View Questions on ICHR
Just Eat Takeaway.com N.V. (GRUB)
- P/E (TTM): -4.7X Cap: $7.22B
- View GRUB Profile
- View Questions on GRUB
Nektar Therapeutics (NKTR $59.92)
- $59.92 Cap: $1.13B
- View NKTR Profile
- View Questions on NKTR
Rapid7 Inc. (RPD $18.68)
- $18.68 P/E (TTM): 44.07X Cap: $1.20B
- View RPD Profile
- View Questions on RPD

Q: Can you recommend 8-10 small -mid cap USA stocks with high growth potential, good to excellent balance sheets that your team at 5i would own or do own and consider a long term buy. Can be from any sectors. Please exclude the following names, as these are currently already owned: BOX, FLIR, ANET, TEAM, GRUB, LLL, CGNX, ALGN

Read Answer Asked by Aaron on June 06, 2018